SURAL NERVE GRAFTS IN FORNIX LESIONS
穹窿病变中的腓肠神经移植物
基本信息
- 批准号:3416443
- 负责人:
- 金额:$ 13.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-01-01 至 1994-12-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer's disease Cebidae Macaca mulatta acetylcholine age difference aging amyloid proteins artificial immunosuppression autologous transplantation behavior test cognition disease /disorder model enzyme linked immunosorbent assay experimental brain lesion hippocampus histochemistry /cytochemistry homologous transplantation immunocytochemistry in situ hybridization nervous system regeneration nervous system transplantation neural degeneration neuroanatomy neurochemistry neurofilament proteins neuronal guidance neurotrophic factors prosencephalon
项目摘要
Converging lines of evidence have suggested that cholinergic basal
forebrain [CBF] neurons are sensitive to the trophic effects of a number of
growth factors including nerve growth factor [NGF] and fibroblast growth
factor [FGF]. Furthermore, these neurons require NGF for their survival
and phenotypic differentiation. CBF neurons consistently degenerate in
Alzheimer's disease (AD). These data, along with the substantial clinical
and experimental literature implicating CBF systems in normal cognitive
processes, has led to the hypothesis that administration of growth factors
such as NGF may prevent the degeneration of CBF neurons in AD. One
shortcoming of this contention is the paucity of supporting data gathered
in nonhuman primates.
This proposal aims to examine the structural and functional
consequences of peripheral nerve grafts upon nonhuman primate CBF neurons.
Following peripheral nerve transection, Schwann cells which ensheath
peripheral nerves begin de novo synthesis of a number of growth factors and
neurite promoting molecules including NGF, ciliary neuronotropic factor,
brain derived neuronotrophic factor, laminin, and possibly FGF. We have
previously demonstrated that peripheral nerve provides trophic and neurite
promoting effects upon primate adrenal chromaffin cells following grafting
into parkinsonian monkeys. Recently we have demonstrated that axotomized
monkey CBF neurons can be rescued following peripheral nerve grafts if the
implant precedes neuronal degeneration. Peripheral nerve grafts also
invoke a cholinergic sprouting response. The proposed experiments intend
to expand upon these latter observations. The long-term trophic and
neurite promoting effects of peripheral nerve implants will be assessed and
the dependence of these effects upon the continued presence of the graft
will be determined. NGF levels produced by the implant will be quantified
over time. Possible detrimental effects of peripheral nerve implantation
will be determined via in situ hybridization for the beta amyloid precursor
protein and with an immunocytochemical analysis of abnormally synthesized
cytoskeletal proteins. The ability of aged primate transected nerve to
manifest trophic influences upon NGF sensitive cells will also be
determine. NGF production in severed peripheral nerves from young and aged
monkeys will be compared in vitro and following grafting. The ability of
autologous peripheral nerve grafts to prevent experimentally induced CBF
neural degeneration in aged monkeys and the ability of such grafts to
reverse age-related cognitive dysfunction will also be assessed. These
studies will establish whether peripheral nerve grafts are a good donor
source for reversing the consequences of basal forebrain degeneration in
primates and will shed light on whether this approach is relevant for the
treatment of AD.
越来越多的证据表明,胆碱能基础
前脑[CBF]神经元对一些营养作用敏感,
生长因子,包括神经生长因子[NGF]和成纤维细胞生长
因子[FGF]。 此外,这些神经元的生存需要NGF
和表型分化。 CBF神经元持续变性,
阿尔茨海默病(AD)。这些数据,沿着大量的临床试验,
和实验文献暗示CBF系统在正常认知
过程,导致了这样的假设,即生长因子的管理
如NGF可防止AD时CBF神经元的变性。 一
这一论点的缺点是缺乏收集的支持数据
在非人类灵长类动物中。
本提案旨在审查
外周神经移植物对非人灵长类CBF神经元的影响。
在周围神经切断后,包鞘的雪旺细胞,
周围神经开始从头合成许多生长因子,
神经突促进分子包括NGF,睫状神经营养因子,
脑源性神经营养因子,层粘连蛋白,可能还有FGF。 我们有
以前证明,周围神经提供营养和神经突,
移植对灵长类肾上腺嗜铬细胞的促进作用
变成帕金森病猴子 最近,我们已经证明,
猴CBF神经元可以在周围神经移植后被拯救,
植入会导致神经元变性 周围神经移植物还
引起胆碱能发芽反应 拟议的实验旨在
来扩展后面这些观察。 长期营养和
将评估周围神经植入物的神经突促进作用,
这些效应依赖于移植物的持续存在
将被确定。 将对植入物产生的NGF水平进行定量
随着时间周围神经植入术可能产生的不良影响
将通过β淀粉样蛋白前体的原位杂交来确定
蛋白质,并与异常合成的免疫细胞化学分析
细胞骨架蛋白 老年灵长类动物切断神经的能力
对NGF敏感细胞的明显营养影响也将是
决定。 年轻人和老年人周围神经切断后神经生长因子的产生
将在体外和移植后对猴进行比较。 的能力
自体周围神经移植物预防实验性诱发的CBF
老年猴子的神经退化和这种移植物的能力,
还将评估反向年龄相关的认知功能障碍。 这些
研究将确定周围神经移植物是否是一个好的供体
逆转基底前脑退化的后果的来源,
灵长类动物,并将阐明这种方法是否与
治疗AD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey H Kordower其他文献
Gene Therapy for Parkinson’s Disease: Still a Hot Topic?
帕金森病的基因治疗:仍是热门话题吗?
- DOI:
10.1038/npp.2014.235 - 发表时间:
2014-12-08 - 期刊:
- 影响因子:7.100
- 作者:
Jeffrey H Kordower - 通讯作者:
Jeffrey H Kordower
Lewy body pathology in long-term fetal nigral transplants: is parkinson's disease transmitted from one neural system to another?
长期胎儿黑质移植中的路易体病理:帕金森病是否从一个神经系统传播到另一个神经系统?
- DOI:
10.1038/npp.2008.161 - 发表时间:
2008-12-12 - 期刊:
- 影响因子:7.100
- 作者:
Jeffrey H Kordower;Patrik Brundin - 通讯作者:
Patrik Brundin
Missing pieces in the Parkinson's disease puzzle
帕金森病拼图中缺失的部分
- DOI:
10.1038/nm.2165 - 发表时间:
2010-05-23 - 期刊:
- 影响因子:50.000
- 作者:
Jose A Obeso;Maria C Rodriguez-Oroz;Christopher G Goetz;Concepcion Marin;Jeffrey H Kordower;Manuel Rodriguez;Etienne C Hirsch;Matthew Farrer;Anthony H V Schapira;Glenda Halliday - 通讯作者:
Glenda Halliday
Jeffrey H Kordower的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey H Kordower', 18)}}的其他基金
Combining synucleinopathy and mitochondrial deficits in a novel mouse model of Parkinsons disease
在帕金森病的新型小鼠模型中结合突触核蛋白病和线粒体缺陷
- 批准号:
10531950 - 财政年份:2019
- 资助金额:
$ 13.88万 - 项目类别:
Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD
纹状体 CaV1.3 钙通道的基因沉默作为 PD 的有效抗运动障碍疗法
- 批准号:
9975239 - 财政年份:2018
- 资助金额:
$ 13.88万 - 项目类别:
Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD
纹状体 CaV1.3 钙通道的基因沉默作为 PD 的有效抗运动障碍疗法
- 批准号:
10427300 - 财政年份:2018
- 资助金额:
$ 13.88万 - 项目类别:
Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD
纹状体 CaV1.3 钙通道的基因沉默作为 PD 的有效抗运动障碍疗法
- 批准号:
10179502 - 财政年份:2018
- 资助金额:
$ 13.88万 - 项目类别:
Does alpha synuclein strain or GCase enzyme activity drive clinical aggression in GBA-PD?
α 突触核蛋白菌株或 GCase 酶活性是否会导致 GBA-PD 患者的临床攻击行为?
- 批准号:
9789065 - 财政年份:2018
- 资助金额:
$ 13.88万 - 项目类别:
Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD
纹状体 CaV1.3 钙通道的基因沉默作为 PD 的有效抗运动障碍疗法
- 批准号:
9789969 - 财政年份:2018
- 资助金额:
$ 13.88万 - 项目类别:
Human Cell and Gene Therapy in Parkinsonian monkeys
帕金森猴的人类细胞和基因治疗
- 批准号:
8397422 - 财政年份:2012
- 资助金额:
$ 13.88万 - 项目类别:
Human Cell and Gene Therapy in Parkinsonian monkeys
帕金森猴的人类细胞和基因治疗
- 批准号:
8484898 - 财政年份:2012
- 资助金额:
$ 13.88万 - 项目类别:
Human Neural Stem Cells for HD: Technical and Empirical Advances
人类神经干细胞治疗 HD:技术和经验进展
- 批准号:
8095989 - 财政年份:2011
- 资助金额:
$ 13.88万 - 项目类别:
Human Neural Stem Cells for HD: Technical and Empirical Advances
人类神经干细胞治疗 HD:技术和经验进展
- 批准号:
8269640 - 财政年份:2011
- 资助金额:
$ 13.88万 - 项目类别:
相似海外基金
Doctoral Dissertation Improvement: Dental Microstructure and Growth in the Cebidae
博士论文改进:齿科动物的牙齿微观结构和生长
- 批准号:
0622479 - 财政年份:2006
- 资助金额:
$ 13.88万 - 项目类别:
Standard Grant